ClinicalTrials.gov
public full text
Public Domain
Antidepressants and Bone Mineral Density
The aim of this five arm randomized trial was thus to compare selective serotonin reuptake inhibitor (SSRI)sertraline and citalopram to a dual reuptake inhibitor venlafaxine, a nor-adrenaline reuptake inhibitor reboxetine and a control group receiving placebo, with the primary endpoint being bone mineral density, and secondary endpoints being bone turnover markers.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Nutrition Status, BMD, and SSRIs#1074183
- Sertraline for Preventing Post-stroke Depression and Improving Rehabilitation Outcomes#805299
- Sertraline as an antidepressant and inflammatory cytokines in depressive disorders : a systematic review and meta-analysis of randomized double-blind placebo-controlled trials#443711
- Chronic Kidney Disease Antidepressant Sertraline Trial#321646
- SSRI and Buprenorphine#903918
Record · ID 854353
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive